2EGQ | pdb_00002egq

Solution structure of the fourth LIM domain from human four and a half LIM domains 1

External Resource: Annotation

Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	LIM_N_2	e2egqA1	A: few secondary structure elements	X: Glucocorticoid receptor-like	H: LIM domain-like	T: LIM domain-like	F: LIM_N_2	ECOD (1.6)
A	LIM_C_2	e2egqA2	A: few secondary structure elements	X: Glucocorticoid receptor-like	H: LIM domain-like	T: LIM domain-like	F: LIM_C_2	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	2.10.110.10	Mainly Beta	Ribbon	Cysteine Rich Protein	Cysteine Rich Protein	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00412	LIM domain (LIM)	LIM domain	This family represents two copies of the LIM structural domain.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	FHL1 protein	protein binding binding transmembrane transporter binding potassium channel regulator activity transporter activator activity channel regulator activity potassium channel activator activity molecular function activator activity ion channel regulator activity molecular function regulator activity channel activator activity transporter regulator activity cation binding transition metal ion binding protein binding binding transmembrane transporter binding potassium channel regulator activity transporter activator activity channel regulator activity potassium channel activator activity molecular function activator activity ion channel regulator activity molecular function regulator activity channel activator activity transporter regulator activity cation binding transition metal ion binding zinc ion binding ion binding metal ion binding small molecule binding	developmental process cellular developmental process cell differentiation cellular process anatomical structure morphogenesis anatomical structure development animal organ development animal organ morphogenesis regulation of cell cycle phase transition regulation of cellular process negative regulation of biological process negative regulation of cell cycle cell cycle phase transition regulation of cell cycle G1/S phase transition developmental process cellular developmental process cell differentiation cellular process anatomical structure morphogenesis anatomical structure development animal organ development animal organ morphogenesis regulation of cell cycle phase transition regulation of cellular process negative regulation of biological process negative regulation of cell cycle cell cycle phase transition regulation of cell cycle G1/S phase transition cell cycle G1/S phase transition mitotic cell cycle negative regulation of mitotic cell cycle regulation of mitotic cell cycle negative regulation of cellular process negative regulation of cell cycle phase transition cell cycle regulation of cell cycle cell cycle process negative regulation of G1/S transition of mitotic cell cycle regulation of biological process negative regulation of mitotic cell cycle phase transition regulation of cell cycle process negative regulation of cell cycle G1/S phase transition biological regulation negative regulation of cell cycle process regulation of mitotic cell cycle phase transition mitotic cell cycle process regulation of G1/S transition of mitotic cell cycle G1/S transition of mitotic cell cycle mitotic cell cycle phase transition regulation of membrane depolarization membrane depolarization regulation of biological quality regulation of atrial cardiac muscle cell membrane depolarization regulation of membrane potential G2/M transition of mitotic cell cycle cell cycle G2/M phase transition regulation of G2/M transition of mitotic cell cycle regulation of cell cycle G2/M phase transition negative regulation of cell cycle G2/M phase transition negative regulation of G2/M transition of mitotic cell cycle muscle structure development muscle organ development regulation of growth regulation of cellular component organization growth negative regulation of cell growth regulation of cell growth cell growth cellular component organization negative regulation of growth cellular component organization or biogenesis regulation of localization positive regulation of cation transmembrane transport regulation of potassium ion transport transport monoatomic ion transmembrane transport positive regulation of biological process potassium ion transmembrane transport regulation of monoatomic ion transmembrane transport metal ion transport monoatomic cation transmembrane transport localization positive regulation of monoatomic ion transport positive regulation of transmembrane transport monoatomic ion transport positive regulation of monoatomic ion transmembrane transport monoatomic cation transport regulation of metal ion transport positive regulation of cellular process regulation of transport regulation of monoatomic ion transport regulation of potassium ion transmembrane transport establishment of localization transmembrane transport positive regulation of potassium ion transport regulation of transmembrane transport positive regulation of transport positive regulation of potassium ion transmembrane transport regulation of monoatomic cation transmembrane transport potassium ion transport	cellular anatomical structure anchoring junction cell junction focal adhesion cell-substrate junction intracellular anatomical structure cytoplasm cytosol cell periphery plasma membrane membrane membrane-bounded organelle intracellular organelle organelle cellular anatomical structure anchoring junction cell junction focal adhesion cell-substrate junction intracellular anatomical structure cytoplasm cytosol cell periphery plasma membrane membrane membrane-bounded organelle intracellular organelle organelle nucleus intracellular membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR056807	FHL1/2/3/5, N-terminal LIM domain	Domain
A	IPR042997	Four and a half LIM domains protein 1	Family
A	IPR001781	Zinc finger, LIM-type	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q13642	myopathy, reducing body, X-linked, early-onset, severe myopathy, reducing body, X-linked, childhood-onset X-linked myopathy with postural muscle atrophy X-linked scapuloperoneal muscular dystrophy Emery-Dreifuss muscular dystrophy Liver Cirrhosis, Experimental X-linked Emery-Dreifuss muscular dystrophy hypertrophic cardiomyopathy ulcerative colitis limb-girdle muscular dystrophy lung cancer malignant ependymoma adrenal cortex carcinoma medulloblastoma muscular dystrophy myopathy, reducing body, X-linked, early-onset, severe myopathy, reducing body, X-linked, childhood-onset X-linked myopathy with postural muscle atrophy X-linked scapuloperoneal muscular dystrophy Emery-Dreifuss muscular dystrophy Liver Cirrhosis, Experimental X-linked Emery-Dreifuss muscular dystrophy hypertrophic cardiomyopathy ulcerative colitis limb-girdle muscular dystrophy lung cancer malignant ependymoma adrenal cortex carcinoma medulloblastoma muscular dystrophy atopic eczema breast fibroadenoma oligodendroglioma pancreatic intraductal papillary-mucinous carcinoma dermatomyositis psoriasis Down syndrome Sjogren syndrome intellectual disability Uruguay Faciocardiomusculoskeletal syndrome lung carcinoma malignant glioma arthrogryposis muscle tissue disease myopathy breast cancer chronic kidney disease ovarian cancer Crohn disease pancreatic intraductal papillary-mucinous neoplasm dilated cardiomyopathy reducing body myopathy ductal breast carcinoma in situ head and neck cancer subependymal giant cell astrocytoma invasive ductal breast carcinoma lung adenocarcinoma malignant colon neoplasm malignant mesothelioma muscular disease astrocytic tumor breast carcinoma non-small cell lung carcinoma chronic obstructive pulmonary disease pancreatic ductal adenocarcinoma cystic fibrosis pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia distal myopathy

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.